Evidence map›Paper›PMID 42338731›Full record

ArticleFrontiers in cardiovascular medicine2026

Hereditary transthyretin amyloid cardiomyopathy caused by the rare TTR p.Ser43Asn variant in an Asian family: a case report.

Bo Song, Youfu He, Xinghui Liu, Hui Liu, Fawang Du, Jiren Wang, Hongwen Tan, Changhai Zhang, Ping Zhang

Abstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in cardiovascular medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Bo SongDepartment of Cardiology, Guizhou Provincial People's Hospital, Guiyang, Guizhou Province, China.
Youfu HeDepartment of Cardiology, Guizhou Provincial People's Hospital, Guiyang, Guizhou Province, China.
Xinghui LiuDepartment of Cardiology, Guizhou Provincial People's Hospital, Guiyang, Guizhou Province, China.
Hui LiuDepartment of Cardiology, Guizhou Provincial People's Hospital, Guiyang, Guizhou Province, China.
Fawang DuDepartment of Cardiology, Guizhou Provincial People's Hospital, Guiyang, Guizhou Province, China.
Jiren WangDepartment of Cardiology, Guizhou Provincial People's Hospital, Guiyang, Guizhou Province, China.
Hongwen TanDepartment of Cardiology, Guizhou Provincial People's Hospital, Guiyang, Guizhou Province, China.
Changhai ZhangDepartment of Cardiology, Guizhou Provincial People's Hospital, Guiyang, Guizhou Province, China.
Ping ZhangDepartment of Cardiology, Guizhou Provincial People's Hospital, Guiyang, Guizhou Province, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Transthyretin amyloid cardiomyopathy (ATTR-CM) is an infiltrative cardiomyopathy that may occur in hereditary or wild-type forms. Although more than 150 transthyretin ( Case presentation: This report describes a mainland Chinese family carrying the rare Conclusion: This family report expands the clinical spectrum associated with the rare

Indexed as

Asian populationcardiac amyloidosiscase reporthereditary transthyretin amyloidosishypertrophic cardiomyopathy mimictransthyretin amyloid cardiomyopathyTTR c.128G > A (p.Ser43Asn)

Identifiers

PMID42338731
PMCPMC13283870

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.